- Research article
- Open Access
Engraftment of enteric neural progenitor cells into the injured adult brain
BMC Neuroscience volume 17, Article number: 5 (2016)
A major area of unmet need is the development of strategies to restore neuronal network systems and to recover brain function in patients with neurological disease. The use of cell-based therapies remains an attractive approach, but its application has been challenging due to the lack of suitable cell sources, ethical concerns, and immune-mediated tissue rejection. We propose an innovative approach that utilizes gut-derived neural tissue for cell-based therapies following focal or diffuse central nervous system injury.
Enteric neuronal stem and progenitor cells, able to differentiate into neuronal and glial lineages, were isolated from the postnatal enteric nervous system and propagated in vitro. Gut-derived neural progenitors, genetically engineered to express fluorescent proteins, were transplanted into the injured brain of adult mice. Using different models of brain injury in combination with either local or systemic cell delivery, we show that transplanted enteric neuronal progenitor cells survive, proliferate, and differentiate into neuronal and glial lineages in vivo. Moreover, transplanted cells migrate extensively along neuronal pathways and appear to modulate the local microenvironment to stimulate endogenous neurogenesis.
Our findings suggest that enteric nervous system derived cells represent a potential source for tissue regeneration in the central nervous system. Further studies are needed to validate these findings and to explore whether autologous gut-derived cell transplantation into the injured brain can result in functional neurologic recovery.
Diseases of the nervous system belong to the most challenging maladies and have been recognized as one of the greatest threats to public health [1–5]. With a current lack of effective therapies for most neurological disorders, such as neurodegenerative diseases, traumatic brain injury, or long-term neurotoxicity from cancer therapy, and a steadily growing aging population with increasing prevalence of neurological disorders, there is an urgent need to develop strategies for nervous system repair.
Neural plasticity and nervous system regeneration in the setting of injury or disease is dependent on the activity of neural stem and progenitor cells that reside in a specialized, regulatory neurovascular environment [6–11]. Optimizing the cellular and molecular factors that control the neural stem cell niche has evolved as an attractive strategy to promote central nervous system (CNS) repair following focal and diffuse brain injury . However, the damaged central nervous system has a limited capacity for endogenous regeneration. Therefore, exogenous stem cell-based therapies remain a promising avenue to promote tissue and functional repair [13–15]. Experimental studies designed to transplant exogenous neural cells into the injured CNS have largely failed due to multiple reasons, including technical and ethical factors regarding the source of donor cells, immune-mediated transplant rejection, and insufficient integration of transplanted cells into the host cellular network [16, 17].
Identifying an easily accessible, autologous, and reliable source of neural progenitor cells would address many of the current challenges and might be useful in the treatment of a wide range of neurologic disorders. The objective of this study was to test the hypothesis that neural progenitor cells derived from the enteric nervous system (ENS) could have a potential role in CNS repair. We and others have previously shown that enteric neuronal stem and progenitor cells (ENSCs) can be successfully isolated from the postnatal ENS, propagated in vitro, and transplanted into the gut in vivo [18–20]. Building on this knowledge, we transplanted gut-derived enteric neural progenitor cells into brain-injured mice.
We demonstrate that following both systemic and local administration, transplanted cells (1) home to neurogenic niches, (2) survive and differentiate into neuronal and glial lineages, and are able to (3) stimulate endogenous neurogenesis. These results support the potential use of autologous gut-derived neural tissue for cell replacement therapy in the injured CNS.
The Institutional Animal Care and Use Committee of the Massachusetts General Hospital approved all experiments. We used two strains of genetically engineered animals as the source of donor cells to facilitate their in vivo tracking based on the expression of fluoresecent proteins: Actb-DsRed mice (strain Tg(CAG-DsRed*MST)1Nagy/J; Jackson Labs Stock #005441) were purchased from the Jackson Laboratory. All cells in Actb-DsRed mice are fluorescently labeled . We also used transgenic Nestin-GFP mice, in which GFP expression is controlled under the Nestin promoter . Nestin-GFP mice were used as donor mice initially, but in light of better breeding efficiency, we used Actb-DsRed donor mice in later experiments. Recipient mice were wild-type C57BL/6.
Isolation and propagation of ENSCs in vitro
Mice were sacrificed on postnatal day 14-21 (P14-21), and the gastrointestinal tract from duodenum to anus was removed. The longitudinal muscle-myenteric plexus (LMMP) layer was separated and dissociated with dispase (250 μg/ml; StemCell Technologies, Vancouver, Canada) and collagenase XI (1 mg/ml; Sigma Aldrich, St. Louis, MO, USA) at 37 °C for 1 h. The cell suspension was passed through a 40μm cell strainer and cultured at a density of 50,000 cells/mL in proliferation medium, consisting of Neurocult NSC Basal Medium (StemCell Technologies) supplemented with 20 ng/ml epidermal growth factor (EGF; StemCell Technologies) and 10 ng/ml basic fibroblast growth factor (bFGF; StemCell Technologies), 0.0002 % Heparin (StemCell Technologies) and 100U/ml Penicillin–Streptomycin (Life Technologies) for 7–10 days to form enteric neurospheres. Neurospheres were passaged every 7–10 days with gentle Accutase (StemCell Technologies) dissociation followed by re-plating in culture medium containing conditioned medium (1:2 mix). ENSCs retain the capacity to form neurospheres following up to five passages. For consistency, we used secondary neurospheres throughout this study.
To induce differentiation, neurospheres were dissociated with Accutase (StemCell Technologies) then passed though a 40 μm cell strainer and plated at 50,000 cells/mL on glass-bottom chamber slides coated with 20 mg/mL fibronectin (Biomedical Technologies, Ward Hill, MA, USA). Cells were cultured for 7 days in NeuroCult NSC Differentiation Medium (StemCell Technologies) prior to immunohistochemistry.
Brain injury models
Closed head injury (concussion model)
Mice were injured daily for 5 consecutive days, and transplanted into mice 3 days after the last injury. During injury, mice were anesthetized with 4 % isoflurane for 45 s, grasped by the tail, and placed prone. The head of the animal was placed directly beneath the opening of a metal tube conduit. A 54-g metal bolt was dropped onto the midline of the head from a height of 38 inches. Sham-injured mice were subjected to anesthesia but no weight drop.
Mice were treated with either focal brain or whole body irradiation. For focal brain irradiation, the mouse body was protected with a customized lead shield and irradiation administered to anesthetized mice as a single fraction of 10 Gy using a Cs-irradiation source. Whole body irradiation was performed using a sublethal dose of 5 Gy in a similar fashion.
Prior to transplantation, dissociated ENSCs were pulsed for 2–4 h with 10 µM BrdU (3.3 µg/ml) to determine in vivo DNA synthesis as a surrogate marker for cell proliferation. For cell transplantation directly into the brain, 4–6 week-old wild-type mice were anesthetized with isoflurane and ENSCs (5000 cells per recipient) were stereotactically injected into various brain regions using a Kopf stereotaxic frame (David Kopf Instruments; Tujunga, CA, USA). Injected regions included the lateral subventricular zone (SVZ) (coordinates: AP 1.0 mm, ML 1.0 mm, DV 2.1 mm), the dentate gyrus (DG) of the hippocampus (coordinates: AP −1.70 mm, ML 0.70 mm, DV 2.04 mm), and the left lateral ventricle (LV) (coordinates: AP 0 mm, ML 1 mm, DV 2.5 mm). Systemic cell transplantation was performed via tail vein injection of ENSCs (100–400 k cells per recipient, depending on the experiment).
Cells or tissues were fixed, washed, and permeabelized with 0.1 % Triton X-100 for 30 min and then exposed to the following primary antibodies: mouse anti-Tuj1 (1:100, Covance, Dedham, MA, USA), mouse anti-Hu C/D (1:100, Life Technologies, Carlsbad, CA, USA), rabbit anti-p75 (1:500, Promega, Madison, WI, USA), rabbit anti-Sox2 (1:50, Abcam, Cambridge, MA, USA), rabbit anti-Doublecortin (1:250, Abcam), rabbit anti-Olig2 (1:250, Millipore, Billerica, MA), goat anti-GFAP (1:500, Abcam), goat anti-GFP (1:400, Rockland, Limerick, PA, USA). Secondary antibodies included goat anti-mouse IgG Alexa Fluor 546, goat anti-rabbit Alexa Fluor 488, donkey anti-goat Alexa Fluor 488, donkey anti-goat Alexa Fluor 546, donkey anti-mouse Alexa Fluor 546, donkey anti-mouse Alexa Fluor 488, all from Life Technologies (Carlsbad, CA, USA). Cell nuclei were stained with DAPI (Vector Labs, Burlingame, CA, USA).
Z-stack images were obtained with laser scanning confocal microscopy using a Nikon A1R confocal microscope, providing high-resolution images of up to 4096 × 4096 pixels with a galvano scanner.
Postnatal gut-derived ENSCs can be isolated and propagated in culture
To determine whether ENSCs could serve as a potential source for CNS repair, the intestinal tract of 2–3 week-old postnatal Actb-DsRed mice was removed and ENSCs isolated and propagated, as previously described [23, 24]. ENSCs are able to form neurospheres in culture and these spheres can be labeled with markers for enteric neuronal progenitors (Sox2 and p75) as well as neuronal (Tuj1) and glial (GFAP) markers (Fig. 1). We have previously shown that enteric neurospheres contain 37.3 ± 4.2 %; neurons and 27.6 ± 1.7 glial cells (Hotta et al. in press). Dissociated neurospheres give rise to Tuj1 + and GFAP + cells, consistent with neuronal and glial differentiation, respectively (Fig. 1B, C, F, G).
Following intracerebral injection ENSCs survive and stimulate endogenous neurogenesis
To determine whether gut-derived neural progenitor cells can survive after transplantation into the adult brain, ENSCs were prepared, pulsed with BrdU in vitro, and injected as a cell suspension (5000 cells in 3 µl volume) into various brain regions (lateral subventricular zone, dentate gyrus of the hippocampus, and lateral ventricle). In this pilot experiment, Nestin-GFP-labeled cells were used  with subsequent experiments using Actb-DsRed-labeled cells. Mice were sacrificed after 2 and 4 weeks following transplantation (n = 5 per group). Immunohistochemistry identifies gut-derived GFP+ neural precursors in the brains of transplanted animals at both time points. Following injection into the lateral ventricle, cells were found along the inner lining of the ependymal layer of the ventricular system (Fig. 2B, C) and along the needle tract (not shown). GFP + cells were also seen in the brain parenchyma in and around the dentate gyrus following transplantation into the hippocampal region (Fig. 2D–G), where rare transplanted cells were identified to display a branched morphology with apparent integration into the granular cell layer of the dentate gyrus (Fig. 2D). This tissue integration was only observed at 4 weeks, but not at 2 weeks after transplantation.
Cells co-expressing both GFP and BrdU were identified, suggesting that proliferating ENSCs survive for at least 4 weeks after transplantation (Fig. 2E). A subpopulation of transplanted cells co-expressed doublecortin, a marker of immature neurons (Fig. 2F–H), and GFAP, a glial cell marker (Fig. 2E). Interestingly, enhanced endogenous neurogenesis, as evidenced by focally increased doublecortin expression, was observed in the granular cell layer of the dentate gyrus in close proximity to the location of the transplanted cells (Fig. 2G).
ENSCs delivered systemically home to the injured brain
Based on our initial experiments employing cell delivery via intracerebral injection, we asked whether systemically delivered cells would be able to home to the sites of injury. We focused on clinically relevant injury models, including an injury model caused by concussion (closed head injury) and an injury model caused by irradiation. Following concussion injury, as described in Methods, Actb-DsRed + ENSCs were injected systemically via tail vein (400,000 cells in 200 µL; n = 3). Controls were injected with cell-free media (n = 2). All mice survived until sacrifice at 10 weeks post transplantation. Systemically administered ENSCs were identified 10 weeks post-transplantation. We found ENSCs homing to the injury site at the cortical surface, as shown in Fig. 3B. Transplanted cells were also identified within the brain parenchyma with apparent migration along white matter tracts (Fig. 3A–C), connecting the injury site with the ipsilateral dentate gyrus (Fig. 3B–G). A significant increase in resident doublecortin + cells, suggestive of increased endogenous neurogenesis, was observed predominantly in areas adjacent to where transplanted cells were identified (Fig. 3E–H). As shown in Fig. 3E, endogenous doublecortin expression was more pronounced in areas where DsRed + cells were located (upper part of the image, Fig. 3E), but not in areas devoid of DsRed + cells (lower part of the image, Fig. 3E). In this experiment, we were not able to detect DsRed + cells that co-labeled with doublecortin.
To determine whether systemically delivered cells also home to other organs, we analyzed lung tissue at 24 h and up to 75 days post-injection. DsRed + ENSCs were found in clusters in the lung at 24 h (Additional file 1: Figure S1), but were not seen at 75 days (not shown).
Systemically delivered ENSCs are identified throughout the brain following radiation injury
Based on our observations we hypothesized that focal brain injury induced by either needle injury or concussion resulted in significant neural and vascular tissue damage, perhaps facilitating the entry of ENSCs into the brain parenchyma.
To explore whether systemically delivered ENSCs are able to enter the central nervous system in the setting of radiation injury, considered less traumatic to the integrity of brain tissue, we performed an experiment using a whole-body (including brain) radiation injury. A sub lethal radiation dose of 5 Gy was administered to mice and ENSCs (100,000 cells in 400 µL) delivered via tail vein 48 h later. Control animals were irradiated and treated with saline injection via tail vein. Animals were examined 14 days following cell delivery. Notably, DsRed + cells were identified in multiple brain regions, and were especially enriched in the germinal zones of the brain (SVZ and DG) and large white matter tracts. Specifically, cells were found in the granular cell layer of the dentate gyrus (Fig. 4B), the corpus callosum, one of the largest white matter tracts in the central nervous system (Fig. 4C), the choroid plexus, a highly vascularized tissue within the ventricular system (Fig. 4D), and the subependymal layer of the lateral ventricle (Fig. 4E–G).
Based on the findings of this experiment, we modified our experimental setting to reflect a more relevant clinical scenario. As whole body irradiation is mainly reserved for patients treated with bone marrow transplantation and is less commonly used in clinical practice, we modified our experimental design to use focal brain irradiation instead, which is frequently applied to patients with brain cancer. The brain of mice was irradiated with 10 Gy in a single fraction and ENSCs (400,000 cells in 400 µL) were delivered via tail vein 48 h later. One experimental group (brain irradiation and ENSC delivery, n = 3) was compared to three control groups (irradiation without ENSCs, n = 3; no irradiation with ENSCs, n = 3; and no irradiation without ENSCs, n = 3). Mice were analyzed 28 days after cell delivery. The results confirmed our preliminary findings, showing the presence of transplanted cells in germinal zones, including the subependymal layer of the ventricular zone (Fig. 5B–D) and the dentate gyrus (Fig. 5I), as well as within white matter tracts (Fig. 5F). Interestingly, many of the transplanted cells identified in mice analyzed at 28 days co-labeled with anti-Hu, a mature neuronal marker. Notably, in non-irradiated animals, DsRed + cells were not readily detectable in the brain. We also did not identify the presence of intravenously-delivered ENSCs in the intestine, suggesting that tissue injury may be a prerequisite for the homing of systemically-delivered cells.
The main objective of this study was to determine whether neural progenitor cells derived from the ENS could survive in the adult mammalian brain after transplantation and could have a potential role in repair of the injured CNS. We found that transplanted ENSCs survive, proliferate, and differentiate into neuronal and glial lineages in vivo. Moreover, transplanted cells migrate extensively along pre-existing pathways and modulate the local microenvironment to stimulate endogenous neurogenesis.
We recently showed that Nestin-expressing neural progenitor cells can be isolated from the intestine and propagated in vitro to give rise to neurospheres capable of differentiating into neuronal and glial lineages . These findings were confirmed in the present study. We have also previously shown that these neurospheres can generate enteric neurons upon transplantation into aneural embryonic hindgut . Interestingly, brain- and gut-derived neurospheres appear to possess phenotypically similar features, including the ability to form dense neuroglial networks in culture and the expression of similar markers of pluripotency . However, their functional properties following transplantation in vivo have not yet been compared. Based on our previous success in isolating, culturing, and transplanting gut-derived neurospheres, and their phenotypic similarities to brain-derived neurospheres, we initiated the present proof-of-principle study.
One of the current challenges compromising the success of cell transplantation strategies for the injured central nervous system has been immune rejection of transplanted cells by the host organism. A particular strength of the current approach was the use of enteric-derived neuronal progenitors, aiming at an elimination of detrimental immune rejection mechanisms if used in an autologous fashion. In addition, cell delivery to injured tissue typically relies on direct donor cell injection, an invasive procedure that results in local tissue damage and other morbidity [25, 26]. In a recent paper, ENS progenitor cells were injected into the hippocampus of irradiated mice, but cell survival was poor and no differentiation was observed . Based on these findings, it remains unclear whether direct tissue injury and local inflammation with microglial activation caused by injection, as reported by Osman et al. , could hinder cell survival and integration into the host. In the present study, we tested the feasibility of systemic delivery to the injured nervous system. To further validate the clinical relevance and practicality of this approach, we used three different injury models, including needle injury, concussion injury, and brain irradiation.
Our findings suggest that gut-derived neural progenitor cells, genetically engineered to express fluorescent proteins, can be successfully transplanted into the injured adult brain. These cells home to sites of injury following systemic cell delivery. Transplanted cells were able to survive at least 10 weeks, proliferate as reflected by BrdU incorporation, and exhibited both neuronal and glial immunophenotypes in vivo . The ENSCs we detected appeared to be anatomically integrated into the tissue as shown in Figs. 2 and 4, although their functional integration into the neuronal network remains unknown. We noted that some fluorescently transplanted cells were negative for both neuronal and glial markers. The fate of these may include either mesenchymal cell types or undifferentiated precursors, as shown by others [28, 29]. Characterizing and optimizing temporal and spatial neuroglial differentiation in the host tissue is a critically important goal.
Notably, transplanted cells appeared to modulate the endogenous niche environment of germinal zones in the adult brain where increased endogenous neuronal differentiation was identified. While injury alone is able to stimulate endogenous neurogenesis  we observed significantly increased numbers of doublecortin + neurons in close proximity to transplanted ENSCs. Furthermore, while direct needle injection causes injury along the needle tract and could account for endogenous neurogenesis as a response to structural tissue damage, we observed a similar pattern of stimulated endogenous neurogenesis following systemic cell delivery in the concussion model (Fig. 3). In our models, the needle injury did not induce any notable increase in neurogenesis in non-transplanted controls and no increase in neurogenesis was observed along the needle tract. Furthermore, the area of neurogenesis was restricted to the site of transplanted ENSCs. Thus, the co-location of newly generated doublecortin-expressing endogenous neurons and the transplanted ENSCs is suggestive of cell transplantation associated endogenous neurogenesis, although this remains to be verified. Importantly, brain or whole body irradiation does not lead to any gross alteration in brain structure in the time periods we studied, although disruption of the functional integrity of the blood–brain barrier does occur . Similarly, the concussion model employed does not lead to any gross alteration in brain structure .
In the present study we used a rodent allogenic transplant model, but our findings support the hypothesis that in humans, autologous gut-derived neural cells may offer a promising cell source for transplantation into the injured CNS. While ENSCs can be isolated from all intestinal segments and using donors of all ages [18, 33, 34], of particular clinical interest are mucosal/submucosal endoscopic biopsies as a strategy to harvest gut-derived progenitor cells. These techniques have been used to isolate and expand ENSc populations  and may provide a suitable source of cells derived from a minimally invasive intervention. Thus our data provide support for further studies to investigate whether small intestinal biopsies from adult donors can serve as a cell source for ENSCs transplantation. In order to validate the functional relevance of this proposed repair strategy, studies in disease-specific preclinical models are needed.
Our findings raise a number of questions that remain unanswered: What are the spatial and temporal dynamics of transplanted cells? What is the proportion of transplanted cells that survive and for how long? What is the extent of neuronal and glial differentiation in each model system, and what is the optimal timing for cell transplantation after injury to yield maximal benefit? What is the mechanism by which transplanted cells might stimulate brain plasticity (e.g., cell integration into the host network system and production of neuroprotective factors)? Perhaps most importantly, do transplanted cells result in functional recovery? While the current study was not designed to address these important questions or to provide quantitative data, our findings suggest that the use of autologous intestinal neural tissues for CNS repair might be a feasible strategy that warrants further investigation and could represent a promising avenue for rapid translation into the clinical arena.
Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6 Suppl):S85–90.
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, et al. Cost of disorders of the brain in Europe 2010. Euro Neuropsychopharmacol J Euro Coll Neuropsychopharmacol. 2011;21(10):718–79.
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Euro Neuropsychopharmacol J Euro Coll Neuropsychopharmacol. 2011;21(9):655–79.
Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, et al. National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med. 2010;153(3):176–81.
Saraceno B. Neurological disorders and public health challenges. In: Document WHO, editor. Geneva. Switzerland: World Health Organization Press; 2006. p. 1–218.
Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, Bostrom E, Westerlund I, Vial C, Buchholz BA, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013;153(6):1219–27.
Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci. 2010;11(5):339–50.
Castilla-Ortega E, Pedraza C, Estivill-Torrus G, Santin LJ. When is adult hippocampal neurogenesis necessary for learning? evidence from animal research. Rev Neurosci. 2011;22(3):267–83.
Kempermann G. Seven principles in the regulation of adult neurogenesis. Euro J Neurosci. 2011;33(6):1018–24.
Lacefield CO, Itskov V, Reardon T, Hen R, Gordon JA. Effects of adult-generated granule cells on coordinated network activity in the dentate gyrus. Hippocampus. 2012;22(1):106–16.
Burghardt NS, Park EH, Hen R, Fenton AA. Adult-born hippocampal neurons promote cognitive flexibility in mice. Hippocampus. 2012;22(9):1795–808.
Dietrich J, Kempermann G. Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol. 2006;557:191–220.
Blaya MO, Tsoulfas P, Bramlett HM, Dietrich WD. Neural progenitor cell transplantation promotes neuroprotection, enhances hippocampal neurogenesis, and improves cognitive outcomes after traumatic brain injury. Exp Neurol. 2015;264:67–81.
Lemmens R, Steinberg GK. Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol. 2013;26(6):617–25.
Wyatt LA, Keirstead HS. Stem cell-based treatments for spinal cord injury. Prog Brain Res. 2012;201:233–52.
Giusto E, Donega M, Cossetti C, Pluchino S. Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol. 2014;260:19–32.
Dunnett SB, Rosser AE. Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease. Neurobiol Dis. 2014;61:79–89.
Hotta R, Stamp LA, Foong JP, McConnell SN, Bergner AJ, Anderson RB, Enomoto H, Newgreen DF, Obermayr F, Furness JB, et al. Transplanted progenitors generate functional enteric neurons in the postnatal colon. J Clin Invest. 2013;123(3):1182–91.
Dettmann HM, Zhang Y, Wronna N, Kraushaar U, Guenther E, Mohr R, Neckel PH, Mack A, Fuchs J, Just L, et al. Isolation, expansion and transplantation of postnatal murine progenitor cells of the enteric nervous system. PLOS One. 2014;9(5):e97792.
Hetz S, Acikgoez A, Voss U, Nieber K, Holland H, Hegewald C, Till H, Metzger R, Metzger M. In vivo transplantation of neurosphere-like bodies derived from the human postnatal and adult enteric nervous system: a pilot study. PLoS One. 2014;9(4):e93605.
Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis. 2004;40(4):241–6.
Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G. Neural stem and progenitor cells in nestin-GFP transgenic mice. J Comp Neurol. 2004;469(3):311–24.
Belkind-Gerson J, Carreon-Rodriguez A, Benedict LA, Steiger C, Pieretti A, Nagy N, Dietrich J, Goldstein AM. Nestin-expressing cells in the gut give rise to enteric neurons and glial cells. Neurogastroenterol Motil. 2013;25(1):61–9.
Belkind-Gerson J, Hotta R, Nagy N, Thomas AR, Graham H, Cheng L, Solorzano J, Nguyen D, Kamionek M, Dietrich J, et al. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm Bowel Dis. 2015;21(4):870–8.
Adami R, Scesa G, Bottai D. Stem cell transplantation in neurological diseases: improving effectiveness in animal models. Front Cell Develop Biol. 2014;2:17.
Osman AM, Zhou K, Zhu C, Blomgren K. Transplantation of enteric neural stem/progenitor cells into the irradiated young mouse hippocampus. Cell Transplant. 2014;23(12):1657–71.
Caldwell MA, He X, Wilkie N, Pollack S, Marshall G, Wafford KA, Svendsen CN. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol. 2001;19(5):475–9.
Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron. 2002;35(4):657–69.
Suarez-Rodriguez R, Belkind-Gerson J. Cultured nestin-positive cells from postnatal mouse small bowel differentiate ex vivo into neurons, glia, and smooth muscle. Stem Cells. 2004;22(7):1373–85.
Saha B, Peron S, Murray K, Jaber M, Gaillard A. Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury. Stem cell research. 2013;11(3):965–77.
Morganti JM, Jopson TD, Liu S, Gupta N, Rosi S. Cranial irradiation alters the brain’s microenvironment and permits CCR2 + macrophage infiltration. PLoS One. 2014;9(4):e93650.
Khuman J, Meehan WP 3rd, Zhu X, Qiu J, Hoffmann U, Zhang J, Giovannone E, Lo EH, Whalen MJ. Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J Cereb Blood Flow Metab. 2011;31(2):778–89.
Micci MA, Pasricha PJ. Neural stem cells for the treatment of disorders of the enteric nervous system: strategies and challenges. Develop Dyn Off Publ Am Assoc Anatomists. 2007;236(1):33–43.
Metzger M, Bareiss PM, Danker T, Wagner S, Hennenlotter J, Guenther E, Obermayr F, Stenzl A, Koenigsrainer A, Skutella T, et al. Expansion and differentiation of neural progenitors derived from the human adult enteric nervous system. Gastroenterology. 2009;137(6):2063–73.
Metzger M, Caldwell C, Barlow AJ, Burns AJ, Thapar N: Enteric nervous system stem cells derived from human gut mucosa for the treatment of aganglionic gut disorders. Gastroenterology 2009; 136(7):2214–25.e2211–13.
JBG conceived of the study, participated in its design and coordination and helped to draft the manuscript, carried out the cell studies and analyzed the tissue. RH carried out many of the cell studies, injected the mice, stained and analyzed the tissue and participated in the design of the study. MW participated in the design of the study, injected the mice and analyzed the tissue. NNayaar stained, sectioned, photographed and analyzed the tissue. NNagy did cell studies and stained, sectioned, photographed and analyzed the tissue. LC participated in the design of the study, injected the mice and analyzed the tissue. AZ stained, sectioned, photographed and analyzed the tissue. AMG conceived of the study, participated in its design and coordination and helped to draft the manuscript. JD conceived of the study, participated in its design and coordination and helped to draft the manuscript, injected the mice, stained and analyzed the tissue. All authors read and approved the final manuscript.
The authors have nothing to acknowledge.
The authors declare that they have no competing interests.
Allan M. Goldstein and Jorg Dietrich contributed equally
About this article
Cite this article
Belkind-Gerson, J., Hotta, R., Whalen, M. et al. Engraftment of enteric neural progenitor cells into the injured adult brain. BMC Neurosci 17, 5 (2016). https://doi.org/10.1186/s12868-016-0238-y
- Enteric neuronal progenitor cells
- Stem cells
- Brain injury
- Cell transplantation
- Brain repair